Synthetic Vitamin D Helps Prevent Some Breast Cancers, Animal St...

Courtesy ScienceDaily  Wed, 04/16/2008 - 10:00

Researchers have found that, in animal studies, a synthetic form of active vitamin D has a substantive preventive effect on the development of both estrogen receptor (ER)-positive and ER-negative breast cancers.

Unlike many of the other synthetic vitamin D agents that have been tested in humans, this compound, known as Gemini 0097, shows no toxicity, they report.

The research team found that daily injections of Gemini 0097 cut growth of ER-positive cancer by 60 percent in rat studies, and reduced...


 

Related items

Team discovers new inhibitors of estrogen-dependent breast cance...
(University of Illinois at Urbana-Champaign) Researchers have discovered a new family of agents that inhibit the growth of estrogen-dependent breast...

Breast Cancer Subtypes Originate From Different Biological Pathw...
There is a biological distinction between breast cancers that depend on hormones and cancers that do not, according to new research. Scientists...

Anchoring Protein Variant Associated with Increased Breast Cance...
Individuals who carry a rare genetic variant have an increased risk of developing breast cancer over their lifetimes, compared with those who do not...

Breast Cancer Subtypes Linked To Survival From Secondary Brain T...
Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases. A new study shows that...

Anti-tumor Effects Are Enhanced By Inhibiting Two Pathways Rathe...
Two independent research groups have found that simultaneous inhibition of two signaling pathways -- mTOR and MAPK signaling pathways -- results in...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com